Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study

Abstract

Background: The objectives of this pilot study were to evaluate treatment quality for the risk factors of hypertension, diabetes and hyperlipidemia as well as the overall treatment quality for patients on an internal nephrology ward. This evaluation included the collection of data concerning the quality of therapeutic drug monitoring, drug use and potential drug-drug interactions. Establishing such baseline information highlights areas that have a need for further therapeutic intervention and creates a foundation for improving patient care, a subject that could be addressed in future clinical pharmacy research projects.

Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices

“…In our study, we showed that multiple drug regimens were needed more with advanced CKD stages, as already demonstrated in a cross-sectional observational Swiss survey including diabetic and CKD patients visiting PCPs [45]. Multimedication and comorbidities are a cause of nonadherence to treatment [46], which could be improved by single pill combination therapy and clinical pharmacist evaluation of adverse effects and drug interactions [45].…”